PHM
43
2
UNH
29
3
HOG
27
-2
CTSH
45
6
AMGN
55
-4
TEL
63
-6
FIS
46
5
DE
66
10
AMAT
63
-3
ALLE
28
9
HRL
27
-2
C
60
2
OMC
54
-8
PCAR
53
-3
AVGO
31
-7
PYPL
32
-5
URBN
47
7
NEE
59
-8
TROW
34
2
MAR
65
3
PHM
43
2
UNH
29
3
HOG
27
-2
CTSH
45
6
AMGN
55
-4
TEL
63
-6
FIS
46
5
DE
66
10
AMAT
63
-3
ALLE
28
9
HRL
27
-2
C
60
2
OMC
54
-8
PCAR
53
-3
AVGO
31
-7
PYPL
32
-5
URBN
47
7
NEE
59
-8
TROW
34
2
MAR
65
3
Financhill
Back

Takeda Pharmaceutical Co., Ltd. 10K Form

Buy
65

TKPHF
Takeda Pharmaceutical Co., Ltd.

Last Price:
$35.73
Seasonality Move:
-3.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TKPHF News And Ratings

See the #1 stock for the next 7 days that we like better than TKPHF

TKPHF Financial Statistics

Sales & Book Value

Annual Sales: $30.1B
Cash Flow: $713.4M
Price / Cash Flow: 13.66
Annual Sales: $30.87
Price / Book: 1.18

Profitability

EPS (TTM): 0.48140
Net Income (TTM): $776.9M
Gross Margin: $16.1B
Return on Equity: 1.63%
Return on Assets: 0.8%

Takeda Pharmaceutical Co., Ltd. Earnings Forecast

Key Takeda Pharmaceutical Co., Ltd. Financial Ratios

  • The Gross Profit Margin over the past 26 years for TKPHF is 53.59%.
  • The Selling, General & Administrative Expenses for TKPHF have been equal to 24.11% of Gross Profit Margin.
  • The Research & Development expenses have been 15.94% of Revenue.
  • The Interest Expense is 172.90% of Operating Income.
  • The Net Earning history of TKPHF is 2.36% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 15 years.

Takeda Pharmaceutical Co., Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TKPHF
Website: takeda.com

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 1.19
Quick Ratio: 0.53

Price-to-Earnings

Trailing P/E Ratio: 82.43
Forward P/E Ratio: 0

TKPHF Technical Analysis vs Fundamental Analysis

Buy
65
Takeda Pharmaceutical Co., Ltd. (TKPHF) is a Buy

Is Takeda Pharmaceutical Co., Ltd. a Buy or a Sell?